CANF

CANF Stock-Based Compensation

$181.00KTTM · USD

Period ending:

CANF FY Stock-Based CompUSD
CANF FY Stock-Based Comp2010-12-31: $177.00K2011-12-31: $83.82K2012-12-31: $389.73K2013-12-31: $787.94K2014-12-31: $212.00K2015-12-31: $109.00K2016-12-31: $309.00K2017-12-31: $195.07K2018-12-31: $535.00K2019-12-31: $385.00K2020-12-31: $355.00K2021-12-31: $466.00K2022-12-31: $263.00K2023-12-31: $261.00K2024-12-31: $362.00K2025-12-31: $340.00K$787.94K$0.00
2010-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CANF stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 16 observations from Dec 31, 2010 to Dec 31, 2025.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
340,000
362,000
261,000
263,000
466,000
355,000
385,000
535,000
195,074
309,000
109,000
211,995
787,939
389,727
83,815
177,000

Compare stock-based compensation

All CANF financial metrics · CANF stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.